HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kanebo Has Settled With 17,000+ Consumers For Brightening Product Injuries

This article was originally published in The Rose Sheet

Executive Summary

Kao Corporation subsidiary offered an update June 9 on its probe into reported vitiligo-like symptoms in consumers who used its Rhododenol-containing skin-brightening products, which were recalled from Asian markets in 2013. More than 17,000 affected individuals have accepted settlement agreements to date.

You may also be interested in...



Kao Restructures To Improve Safety, Communications Amid Kanebo Recall

Kanebo Cosmetics’ safety-assessment and customer-relations functions will merge with Kao Corp.’s operations to leverage the parent firm’s resources and state-of-the-art technologies as a recall of Kanebo brightening products goes on. The Japanese firm is accused of dragging its feet in responding to concerns about its whitening ingredient Rhododenol, linked to confirmed vitiligo-like symptoms in 14,000 users.

Kanebo Recalls Rhododenol-Based Skin Brighteners From Asian Markets

As many as 450,000 units under an array of brands are being recalled by Kao Corporation’s Kanebo Cosmetics unit following reports suggesting that the company’s Rhododenol brightening ingredient can leave white blotches on skin.

Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat

Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS109350

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel